Company intelligence / Profile preview

Laboratoire M2

Sherbrooke, Quebec, Canadathymox.com ↗

Ownership: Private
Employees: ~35
Development stage: Other

Overview

Laboratoire M2 is a Canadian biotechnology company that develops and manufactures biodegradable antimicrobial solutions based on its proprietary Thymox technology. The company's products leverage the natural disinfectant properties of thymol, a botanical extract, to provide effective alternatives to harsh chemicals in animal health, crop protection, and industrial disinfection. Their primary commercial focus is on the dairy industry, where they provide treatments for digital dermatitis, and the institutional cleaning sector. Laboratoire M2 is recognized for its commitment to sustainability, offering non-toxic and environmentally friendly biosecurity solutions.

Therapeutic areas: OtherDermatologyInfectious Diseases
Modalities: Small moleculeBotanical extract
Industry: Non-Drug Biotech

Partnerships

GEA Farm Technologies

Beyond the preview

Go deeper on Laboratoire M2.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laboratoire M2.